ARYA Sciences Acquisition Corp. II (ARYBU) Prices $130M IPO
ARYA Sciences Acquisition Corp. II (ARYBU), announced the pricing of their $130 million IPO last night and the units are expected to begin trading today, Friday, June 5th, under the symbol Nasdaq: ARYBU
While the Company may pursue an initial business combination target in any business or industry, it intends to focus on the healthcare industry in the United States and other developed countries. The Company intends to focus on target businesses with valuations of $300 to $500 million or more and that have the potential to be $1 billion or more market capitalization companies. The Company is led by Chairman Joseph Edelman, Chief Executive Officer Adam Stone, Chief Financial Officer Michael Altman and Chief Business Officer Konstantin Poukalov.
Total SPAC deal count for 2020 year-to-date is now 30 with $9.48 billion in gross proceeds raised. The offering is anticipated to close on Tuesday, June 9, 2020.
Jefferies LLC and Goldman Sachs & Co. acted as joint book-running managers of the offering. Kirkland & Ellis LLP and Skadden, Arps, Slate, Meagher & Flom LLP, were Issuer’s Counsel and Underwriter’s Counsel, respectively. WithumSmith+Brown, PC, acted as auditor.